Upon producing high quality lentiviral particles, Lentigen can easily and efficiently apply its novel LentiMax™ Production system to create and manufacture high-yielding production cell lines capable of producing monoclonal antibodies (Ab) and other therapeutic proteins. Present methods used to create such cell lines are laborious and time-consuming. With the use of Lentigen's LentiMax™ vector and LentiMax™ production system, these master cell lines can be created rapidly and more economically.

These stable cell lines can be used for the production of proteins, antibodies and vaccines. Cell lines created via the LentiMax™ production platform can also be beneficial in pharmaceutical screening.

Our staff of expert scientists can assist with your master cell line development, cell banking, as well as support with regulatory documents, IND preparation, and project management.

Please contact us or call 1-877-MY-LENTI (1-877-695-3684) for more information or a price quote.